Patents by Inventor Renee M. Fleeman

Renee M. Fleeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MRSA biofilm inhibition
    Patent number: 11213507
    Abstract: Provided is a darwinolide compound having a previously undescribed carbon skeleton and the crystalline form thereof. Also provided are processes of isolating darwinolide, compositions comprising darwinolide, and methods of treating infection, such as a methicillin-resistant Staphylococcus aureus biofilm infection.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: January 4, 2022
    Assignees: UNIVERSITY OF SOUTH FLORIDA, UAB RESEARCH FOUNDATION
    Inventors: Bill J. Baker, Lindsey N. Shaw, James Bruce McClintock, Charles D. Amsler, Jacqueline Lee Fries, Witowski G. Christopher, Renee M. Fleeman
  • MRSA BIOFILM INHIBITION
    Publication number: 20210205266
    Abstract: Provided is a darwinolide compound having a previously undescribed carbon skeleton and the crystalline form thereof. Also provided are processes of isolating darwinolide, compositions comprising darwinolide, and methods of treating infection, such as a methicillin-resistant Staphylococcus aureus biofilm infection.
    Type: Application
    Filed: April 17, 2017
    Publication date: July 8, 2021
    Inventors: Bill J. Baker, Lindsey N. Shaw, James Bruce McClintock, Charles D. Amsler, Jacqueline Lee Fries, Witowski G. Christopher, Renee M. Fleeman
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10377733
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: August 13, 2019
    Assignees: University of South Florida, King Abdulaziz University
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10358431
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: July 23, 2019
    Assignees: University of South Florida, King Abdulaziz University
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw
  • Antimicrobials from an epigenetics based fungal metabolite screening program
    Patent number: 10144719
    Abstract: Novel antimicrobial compounds against drug targets such as Eskape pathogens, Leishmania donovani, Mycobacterium tuberculosis, Clostridium difficile, Naegleria fowleri, and cancer are presented herein.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: December 4, 2018
    Assignee: University of South Florida
    Inventors: Danielle H. Demers, Bill J. Baker, Ala Azhari, Renee M. Fleeman, Dennis E. Kyle, Lindsey Neil Shaw